Shanghai - Delayed Quote CNY
DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS)
17.46
+0.06
+(0.34%)
At close: 3:00:01 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Cash Flows from Used in Operating Activities Direct
3,201,892.98
3,173,848.33
3,756,573.44
1,554,994.86
1,953,915.83
Operating Cash Flow
--
3,173,848.33
3,756,573.44
1,554,994.86
1,953,915.83
Investing Cash Flow
-2,407,247.89
-2,303,261.55
-1,293,951.38
-967,696.10
-1,071,241.62
Financing Cash Flow
-648,717.94
-1,649,369.50
-933,569.65
-1,611,967.04
1,209,034.27
End Cash Position
3,151,630.30
2,997,422.94
3,776,205.66
2,247,153.25
3,271,821.54
Capital Expenditure
-1,714,125.94
-1,796,641.34
-1,034,786.75
-1,294,945.82
-792,322.54
Issuance of Debt
2,620,482.48
1,094,372.55
1,095,285.68
145,628.38
1,569,504.33
Repayment of Debt
-1,403,733.87
-974,983.59
-408,817.20
-222,941.23
-118,795.59
Free Cash Flow
1,487,767.04
1,377,206.99
2,721,786.68
260,049.05
1,161,593.29
12/31/2020 - 7/31/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1OT.F Ovid Therapeutics Inc.
0.2260
+15.31%
RXK3.F SELLAS Life Sciences Group, Inc.
1.1500
-2.21%
1VT.MU Viking Therapeutics Inc
22.46
+0.42%
EXOZ eXoZymes, Inc.
13.53
+14.76%
AVBP ArriVent BioPharma, Inc.
21.08
+3.94%
RAPP Rapport Therapeutics, Inc.
11.38
-1.47%
MBX MBX Biosciences, Inc.
8.99
+4.05%
DSGN Design Therapeutics, Inc.
4.0700
+2.78%
SEPN Septerna, Inc.
6.14
+2.85%
ACXP Acurx Pharmaceuticals, Inc.
0.3870
+2.73%